Friday, March 22, 2019

Cardea Bio Gets $7.8M For Biosensors

San Diego-based Cardea Bio, a manufacturer of graphene-based, digital biosensors being used to monitor biological systems using semiconductors, announced this morning that it has raised $7.8M in a Series A-1 financing round. The financing was led by Alexandria Venture Investments, and also included Serra Ventures and other new and existing investors. A

The story you have requested is only available to paid members of the socalTECH.com web site. Premium articles are restricted to paid members only. Please login in order to access this members-only content, or become a member.